Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Arysta Insecticide Product Launch

9 Nov 2009 07:00

RNS Number : 1569C
TyraTech, Inc.
09 November 2009
 



For immediate release

9 November 2009

TYRATECH, INC.

("TyraTech" or "the Company")

Arysta LifeScience Announces Introduction of First TyraTech Insecticide Product 

TyraTech, Inc. (AIM: TYR), a leading independent novel eco-technology company for human, animal and environmental health, is pleased to announce that Arysta LifeScience North America has announced (http://www.arystalifescience.us/default.asp?V_DOC_ID=1963) the introduction of ShooterTM, an insecticide with their Responsive Pest ManagementTM (RPMTM) Technology, which is based on TyraTech Nature's Technology™, to provide an Eco-ResponsiveTM approach to insect control in commercial agriculture. Shooter has been approved for insect control on a large range of crops including bulb, cucurbit, fruiting, root, tuberous and corm vegetables and sweet corn. 

Responsive Pest ManagementTM Technology has been developed by Arysta LifeScience under its strategic partnership agreement with TyraTech, signed in August this year. It is the process of combining nature identical compounds with or without synthetic insecticides and is based on the identification of specific natural compounds that interfere with targeted neurological and olfactory receptors of the insect. When RPMTM Technology compounds come in contact with the sensors, a chain reaction is triggered that repels or kills the insect. 

The Arysta LifeScience plan described in its release of October 21, 2009, notes that the combination of natural compounds with a synthetic insecticide provides a number agronomic and environmental benefits including

Superior control: a new method of control that has been proved effective in numerous field tests. 

Synergy: When a low rate of a synthetic insecticide is combined with RPM Technology, the performance increases dramatically. 

Eco-Responsive: The natural compounds used in RPM Technology are plant-based and when used alone result in an organic product. When natural and synthetic ingredients are combined highly effective control is achieved at significantly reduced rates. 

Safety: None of the specifically targeted insect receptors can be found in humans or animals, which enhances worker safety. The Environmental Protection Agency classifies this technology as Category IV. 

Resistance management: Because it doesn't work like a conventional insecticide, RPM Technology helps break the cycle of resistance. 

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said: "We are delighted that Arysta LifeScience has started the campaign of marketing this excellent new agricultural pest control product. This is the first of a line of products in development, and, clearly demonstrates both the commitment that Arysta LifeScience is making to the commercial plan, and the power of our partnership that brings proprietary discovery and development together with expert commercialization.''

For further information please contact:

TyraTech Inc.

Douglas Armstrong Ph.D., Chief Executive Officer +1 (321) 409 7723

Keith Bigsby, Chief Financial Officer +1 (321) 409 7714

www.tyratech.com

Nomura Code Securities

Charles Walker/Clare Terlouw +44 (0)20 7776 1200

www.nomuracode.com

Buchanan Communications

Lisa Baderoon/ +44 (0)20 7466 5000 Catherine Breen / Stasa Filiplic

www.buchanan.uk.com

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has products on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech's Nature's Technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for consumer and professional pest control. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com 

About Arysta LifeScience Corporation

Headquartered in Tokyo, Japan, Arysta LifeScience is the world's largest privately held crop protection and life science company with 2008 revenues of JPY134 billion (US$1.3 billion). An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specializes in marketing and distribution of respected crop protection brands and life science products in harmony with the needs of global partners. More information on the company is available at: www.arystalifescience.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZGMGMNVKGLZM
Date   Source Headline
8th Nov 20185:25 pmRNSTyratech
2nd Nov 20185:30 pmRNSTyratech
31st Oct 20183:01 pmRNSResult of Special Meeting, Cancellation from AIM
25th Oct 20187:00 amRNSSpecial Meeting and Acquisition Update
18th Oct 20183:00 pmRNSNominee accounts
9th Oct 20182:23 pmRNSPosting of Proxy Statement and Timetable Update
5th Oct 201810:05 amRNSUpdate
28th Sep 20188:50 amRNSInterim Results
28th Sep 20187:00 amRNSConditional Merger Agreement Signed with AMVAC
23rd May 20187:00 amRNSFinal Results
9th May 20187:00 amRNSProgress in 2018 on products and milestones
3rd May 20187:00 amRNSChange of Adviser
24th Jan 20185:44 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSResult of Tender Offer
11th Jan 20181:08 pmRNSTR-1
9th Jan 20185:01 pmRNSTR-1
5th Jan 20187:00 amRNSResult of Tender Offer
28th Dec 20177:00 amRNSResult of Special Meeting
4th Dec 20177:00 amRNSTender Offer to Shareholders and Notice of Meeting
12th Sep 20177:00 amRNSInterim Results for Six Months Ended 30 June 2017
24th Aug 20177:00 amRNSCOMPANY UPDATE AND DATE OF INTERIM RESULTS
4th Jul 20172:29 pmRNSJoint Development and License Agreement
29th Jun 20177:00 amRNSResult of AGM
7th Jun 20177:00 amRNSTYR TR-1: Notification of major interest in shares
9th May 20177:00 amRNSResults for the Year Ended 31 December 2016
28th Apr 20173:24 pmRNSFurther re Notice of Final Results
22nd Mar 20178:57 amRNSTR-1: Notification of major interest in shares
9th Feb 20177:00 amRNSPre-close Trading Update
19th Sep 20163:59 pmRNSDirector/PDMR Shareholding
15th Sep 20161:18 pmRNSDirectors' Dealings
13th Sep 20167:00 amRNSInterim Results for Six Months Ended 30 June 2016
28th Jul 20167:00 amRNSPre Close Trading Update
8th Jun 20163:22 pmRNSResult of AGM and Board Change
22nd Apr 20161:57 pmRNSDirectors' Dealings
15th Apr 201612:03 pmRNSAward of Share Options
15th Apr 201611:57 amRNSDirectors' Dealings
14th Apr 20167:00 amRNSDirectors' Dealings
11th Apr 20167:00 amRNSAppointment of José Barella as Chairman
4th Apr 20167:00 amRNSNotice of Preliminary Results
3rd Feb 201612:31 pmRNSHolding(s) in Company
1st Feb 20161:08 pmRNSDirector's Dealings
1st Feb 20167:00 amRNSPre-close Trading Update
20th Jan 20167:00 amRNSAppointment of Erica H. Boisvert as CFO
13th Jan 20167:00 amRNSNew Product Range Launch & Distribution Agreement
17th Dec 20154:01 pmRNSTR-1: Notification of Major Interest in Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
26th Nov 201512:51 pmRNSTR-1: Notification of Major Interest in Shares
16th Nov 20155:01 pmRNSResult of Special Meeting & Director Shareholdings
4th Nov 20157:00 amRNSPlacing and Subscription to raise £3.16m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.